NRSN icon

NeuroSense Therapeutics

7 hedge funds and large institutions have $286K invested in NeuroSense Therapeutics in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
CF
1
Cantor Fitzgerald
New York
$101K +$101K +79,492 New
XT
2
XTX Topco
Cayman Islands
$58.4K +$16.9K +13,346 +41%
MIH
3
Meitav Investment House
Israel
$50.8K
Citadel Advisors
4
Citadel Advisors
Florida
$43.5K +$43.5K +34,280 New
Commonwealth Equity Services
5
Commonwealth Equity Services
Massachusetts
$16K +$16K +12,625 New
Geode Capital Management
6
Geode Capital Management
Massachusetts
$15.2K
Carson Wealth (CWM LLC)
7
Carson Wealth (CWM LLC)
Nebraska
$1K
AC
8
Armistice Capital
New York
-$1.77M -1,584,000 Closed
Morgan Stanley
9
Morgan Stanley
New York
-$1.68K -1,500 Closed
Qube Research & Technologies (QRT)
10
Qube Research & Technologies (QRT)
United Kingdom
-$60 -54 Closed